Quest Diagnostics director awarded 1,142 RSUs
Quest Diagnostics director Robert B. Carter received an equity award in the form of restricted stock units.
Rhea-AI Filing Summary
Quest Diagnostics director Robert B. Carter received an equity award in the form of restricted stock units. On May 20, 2026, he acquired 1,142 shares of Common Stock at a stated price of $0.00 per share, reflecting a grant or award rather than an open-market purchase.
After this award, Carter directly holds 3,853 shares of Quest Diagnostics common stock in total. The filing does not show any sales or derivative exercises, indicating this was a routine compensation-related equity grant to a board member rather than a trading decision in the market.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,142 shares
Grant/Award
1 txn
Insider
CARTER ROBERT B
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,142 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 3,853 shares (Direct)
Footnotes (1)
- F1. Represents an award of restricted stock units.
Key Figures
Shares granted: 1,142 shares
Grant price: $0.00 per share
Total shares after grant: 3,853 shares
+1 more
4 metrics
Shares granted
1,142 shares
Restricted stock unit award on May 20, 2026
Grant price
$0.00 per share
Compensation-related equity award, not market purchase
Total shares after grant
3,853 shares
Direct holdings following the reported transaction
Transaction code
A (grant, award, or other acquisition)
Non-derivative common stock transaction
Key Terms
restricted stock units, grant, award, or other acquisition, Common Stock
3 terms
restricted stock units financial
"Represents an award of restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
Common Stock financial
""security_title": "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
FAQ
What insider transaction did Quest Diagnostics (DGX) disclose for Robert B. Carter?
Quest Diagnostics reported that director Robert B. Carter received an equity award of 1,142 shares of common stock. The transaction was coded as a grant or award acquisition, not an open-market trade, and increased his directly held position to 3,853 shares.
Was the Quest Diagnostics (DGX) Form 4 transaction a stock purchase or a grant?
The Form 4 shows a grant, not a market purchase. Carter acquired 1,142 common shares at a stated price of $0.00 per share, described as an award of restricted stock units, which is typical for director compensation rather than a discretionary stock buy.
What does the zero price on the Quest Diagnostics (DGX) Form 4 transaction mean?
The $0.00 per-share price indicates the shares were granted as compensation, not bought on the market. Carter’s 1,142-share acquisition represents an award of restricted stock units, so he did not pay cash for the shares reported in this Form 4.
Does the Quest Diagnostics (DGX) Form 4 show any stock sales by Robert B. Carter?
No stock sales are reported in this Form 4. The filing shows only one transaction: an acquisition of 1,142 common shares via a grant of restricted stock units, with no dispositions, tax withholdings, or derivative exercises on the reported date.
AI-generated analysis. How Rhea-AI works. Not financial advice.
